Shares of Koninklijke Philips NV dropped by almost 10% today after the Dutch health technology group reported second-quarter figures that, while superficially stronger than analyst forecasts, raised fresh questions about the quality of those results.
On the top line, comparable sales increased 4% to €4.4 billion, slightly above the consensus estimate of about 3.8% growth. The company also reported an adjusted EBITA margin of 16.4%, well ahead of the 12.1% consensus. However, management disclosed that a €186 million refund related to unlawfully collected U.S. tariffs accounted for 4.2 percentage points of that margin figure.
Removing the tariff refund, the underlying margin performance was essentially flat to marginally down year-over-year. That distinction - between headline outperformance and the operating reality excluding a one-time benefit - was central to investor reaction.
More immediately worrying for the market was an operational miss within Philips’s largest division and a 1% decline in comparable order intake, a key forward-looking gauge for a company that sells capital equipment. CEO Roy Jakobs acknowledged that the timing of several large orders was uneven, with some deals pushed into the third quarter, and he pointed to persistent headwinds in China as an additional drag on momentum.
For the full year, Philips maintained its revenue guidance, reiterating expected comparable sales growth of 3%–4.5%. The company did raise its margin outlook to 13.5%–14.0% from a prior range of 12.5%–13.0%, but management made clear that the improved margin projection was explicitly tied to the tariff refund - a non-recurring benefit that investors quickly discounted.
The sell-off appeared idiosyncratic to Philips rather than driven by a wider market downturn. The pan-European STOXX 600 moved up 0.2% on the day, supported by strong results from consumer and luxury peers, and the Amsterdam AEX had already closed 0.82% lower in the prior session. Philips shares hit a fresh 52-week low of €21.01 intraday, a stark decline from a 52-week high of €27.70, as selling pressure intensified through the trading session.
Market participants cited a combination of concerns that helped precipitate the near-10% drop: the apparent quality-of-earnings issue tied to the tariff refund masking margin weakness, the operational miss in the flagship division, deteriorating order momentum, and unchanged revenue guidance. Collectively, these factors reversed months of share-price recovery and pushed the stock toward the lower boundary of its annual trading range.
Clear summary: Philips posted Q2 comparable sales of €4.4 billion and an adjusted EBITA margin of 16.4%, but a €186 million tariff refund drove much of the margin beat. Underlying margins were flat to slightly down, comparable order intake fell 1%, and the company missed in its largest division. Revenue guidance was unchanged while margin guidance was raised based on the non-recurring refund, prompting a near-10% share price decline to a 52-week low.